REACT-01: Reversing Autoimmunity Through Cell Therapy

Clinical trial NCT06465147 · RECRUITING

Trial details

NCT number: NCT06465147
Sponsor: Seattle Children's Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2024-12-16
Primary completion: 2028-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.